Evaluation of Oxidative Status in Patients Treated with Electroconvulsive Therapy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Electroconvulsive therapy (ECT) is used in the treatment of many psychiatric diseases and this therapy may be effective on antioxidant defence system. In this study, we aimed to evaluate the effects of ECT on oxidative stress. Methods: Fourteen major depression, 11 schizophrenia and 8 bipolar affective disorder patients diagnosed and received ECT treatment, and 37 healthy volunteers enrolled in the study. ECT was applied to all patients. Before ECT, after the first and last ECTs, serum samples were obtained. Serum total antioxidant status (TAS), total oxidant status (TOS), and calculated oxidative stress index (OSI) were measured in patients before and after ECTs. Results: TOS values before ECT were higher in major depression (p=0.005) and schizophrenia (p=0.001) groups compared to the control group. TAS values were lower in major depression (p=0.0001), schizophrenia (p=0.004), bipolar affective disorder (p=0.004) groups compared to the controls. Also OSI values were higher in major depression (p=0.0001), schizophrenia (p=0.001), bipolar affective disorder (p=0.009) groups compared to healthy group. After the last ECT, TOS values were significantly lower compared to TOS values before ECT in major depression (p=0.004) and schizophrenia patients (p=0.004). TAS values after the first ECT were higher compared to values before ECT in major depression patients (p=0.004). After last ECT, OSI values were significantly lower compared to before ECT in schizophrenia patients (p=0.006). Conclusion: As a result, it can be said that ECT did not increase oxidative stress. However, further studies with more patients are needed.
Abstract
Objective: Electroconvulsive therapy (ECT) is used in the treatment of many psychiatric diseases and this therapy may be effective on antioxidant defence system. In this study, we aimed to evaluate the effects of ECT on oxidative stress. Methods: Fourteen major depression, 11 schizophrenia and 8 bipolar affective disorder patients diagnosed and received ECT treatment, and 37 healthy volunteers enrolled in the study. ECT was applied to all patients. Before ECT, after the first and last ECTs, serum samples were obtained. Serum total antioxidant status (TAS), total oxidant status (TOS), and calculated oxidative stress index (OSI) were measured in patients before and after ECTs. Results: TOS values before ECT were higher in major depression (p=0.005) and schizophrenia (p=0.001) groups compared to the control group. TAS values were lower in major depression (p=0.0001), schizophrenia (p=0.004), bipolar affective disorder (p=0.004) groups compared to the controls. Also OSI values were higher in major depression (p=0.0001), schizophrenia (p=0.001), bipolar affective disorder (p=0.009) groups compared to healthy group. After the last ECT, TOS values were significantly lower compared to TOS values before ECT in major depression (p=0.004) and schizophrenia patients (p=0.004). TAS values after the first ECT were higher compared to values before ECT in major depression patients (p=0.004). After last ECT, OSI values were significantly lower compared to before ECT in schizophrenia patients (p=0.006). Conclusion: As a result, it can be said that ECT did not increase oxidative stress. However, further studies with more patients are needed.
참고문헌 (29)
- Halliwell B, "Antioxidants in human health and disease", Annu Rev Nutr, 16, pp.33~50 (1996)
- Erel O, "A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation", Clin Biochem, 37, pp.277~285 (2004)
- Bitanihirwe BK, "Oxidative stress in schizophrenia : an integrated approach", Neurosci Biobehav Rev, 35, pp.878~893 (2011)
- Savas HA, "Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients : impact of past episodes", World J Biol Psychiatry, 7, pp.51~55 (2006)
- Yu YW, "Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response", Neuropsychobiology, 47, pp.137~140 (2003)
- Melike Ceyhan Balci Sengul, "Practice of Acute and Maintenance Electroconvulsive Therapy in the Psychiatric Clinic of a University Hospital from Turkey: between 2007 and 2013", Clinical Psychopharmacology and Neuroscience, 14(1), pp.57~63 (2016), 대한정신약물학회
- Zupan G, "Oxidative stress parameters in different rat brain structures after electroconvulsive shock-induced seizures", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.771~777 (2008)
- Barichello T, "No evidence for oxidative damage in the hippocampus after acute and chronic electroshock in rats", Brain Res, 1014, pp.177~183 (2004)
- Kartalci S, "Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.1689~1694 (2011)
- Pazvantoglu O, "Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile", Psychiatry Clin Neurosci, 63, pp.693~700 (2009)
- Erel O, "A new automated colorimetric method for measuring total oxidant status", Clin Biochem, 38, pp.1103~1111 (2005)
- Jornada LK, "Effects of maintenance electroshock on the oxidative damage parameters in the rat brain", Neurochem Res, 32, pp.389~394 (2007)
- Feier G, "Long lasting effects of electroconvulsive seizures on brain oxidative parameters", Neurochem Res, 31, pp.665~670 (2006)
- Eraković V, "Electroconvulsive shock in rats : changes in superoxide dismutase and glutathione peroxidase activity", Brain Res Mol Brain Res, 76, pp.266~274 (2000)
- Dal-Pizzol F, "Lipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats", Neurosci Lett, 291, pp.179~182 (2000)
- Virit O, "Decreased superoxide dismutase activity after ECT and correlation between higher oxidant levels and poor response to ECT in depression", Arch Neuropsychiatr, 47, pp.247~251 (2010)
- Herken H, "Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression:impact of antidepressant treatment", Arch Med Res, 38, pp.247~252 (2007)
- Khanzode SD, "Oxidative damage and major depression : the potential antioxidant action of selective serotonin re-uptake inhibitors", Redox Rep, 8, pp.365~370 (2003)
- Sarandol A, "Major depressive disorder is accompanied with oxidative stress : short-term antidepressant treatment does not alter oxidative-antioxidative systems", Hum Psychopharmacol, 22, pp.67~73 (2007)
- Cumurcu BE, "Total antioxidant capacity and total oxidant status in patients with major depression : impact of antidepressant treatment", Psychiatry Clin Neurosci, 63, pp.639~645 (2009)
- Raffa M, "Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.1178~1183 (2009)
- Dakhale G, "Oxidative damage and schizophrenia : the potential benefit by atypical antipsychotics", Neuropsychobiology, 49, pp.205~209 (2004)
- Padurariu M, "Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics", Neurosci Lett, 479, pp.317~320 (2010)
- Wang JF, "Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons", J Neurochem, 88, pp.1477~1484 (2004)
- Wang JF, "Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells", Neuroscience, 116, pp.485~489 (2003)
- Selek S, "The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode", J Affect Disord, 107, pp.89~94 (2008)
- Berk M, "N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial", Biol Psychiatry, 64, pp.468~475 (2008)
- Ustundag B, "Total antioxidant response in patients with schizophrenia", Psychiatry Clin Neurosci, 60, pp.458~464 (2006)
- Kosecik M, "Increased oxidative stress in children exposed to passive smoking", Int J Cardiol, 100, pp.61~64 (2005)